Mersana Therapeutics buy Truist Financial Co.
Start price
29.02.24
/
50%
€5.00
Target price
28.02.25
€8.30
Performance (%)
-66.81%
Price
26.09.24
€1.66
Summary
This prediction is currently active. Massive losses of -66.81% have been the result for the BUY prediction by Truist_Financial_Co_. This prediction currently runs until 28.02.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Mersana Therapeutics | - | - |
iShares Core DAX® | -1.471% | 1.895% |
iShares Nasdaq 100 | -0.486% | 4.395% |
iShares Nikkei 225® | -2.115% | 2.450% |
iShares S&P 500 | 0.394% | 3.118% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat